GLP-1 RAs for CVD: Are Cardiologists Ready?
The SELECT trial catapulted GLP-1 RAs into the forefront of CVD prevention, but cardiologists are making their own decisions about whether and how they might integrate these agents into practice.
Stay updated with breaking news from Ipid Management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The SELECT trial catapulted GLP-1 RAs into the forefront of CVD prevention, but cardiologists are making their own decisions about whether and how they might integrate these agents into practice.
Becton Dickinson said on Thursday the FDA cleared its finger-prick blood collection device that could provide a less-invasive option for some commonly ordered lab tests.
Cross-sectional study with a diverse cohort revealed no effect modification associated with Hispanic ethnicity.
A healthy plant-based diet provided a significant reduction in LDL, as well as reductions in fasting insulin and weight compared with a healthy omnivore diet, in an 8-week controlled twin trial.
Expanded prescribing guidelines have not boosted statin use among patients who are at risk for atherosclerotic cardiovascular disease.